Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    21937701 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Lenalidomide in Relapsed or Refractory Classical Hodgkin Lymphoma
Condition: Hodgkin Disease
Intervention: Drug: Lenalidomide

Study has passed its completion date and status has not been verified in more than two years.